药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Arsenic trioxide.
Tazarotene
Lofexidine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Arsenic trioxide.
Tazarotene
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Arsenic trioxide.
Tazarotene
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Arsenic trioxide.
Tazarotene
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Arsenic trioxide.
Tazarotene
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Arsenic trioxide.
Tazarotene
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Arsenic trioxide.
Tazarotene
Oxprenolol
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Arsenic trioxide.
Tazarotene
Mibefradil
The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Arsenic trioxide.
Tazarotene
Clarithromycin
The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Arsenic trioxide.
Tazarotene
Flecainide
The risk or severity of QTc prolongation can be increased when Flecainide is combined with Arsenic trioxide.
Tazarotene
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Arsenic trioxide.
Tazarotene
Propafenone
The risk or severity of QTc prolongation can be increased when Propafenone is combined with Arsenic trioxide.
Tazarotene
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Arsenic trioxide.
Tazarotene
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Arsenic trioxide.
Tazarotene
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Arsenic trioxide.
Tazarotene
Mesoridazine
The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Arsenic trioxide.
Tazarotene
Levosimendan
The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Arsenic trioxide.
Tazarotene
Ondansetron
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Arsenic trioxide.
Tazarotene
Granisetron
The risk or severity of QTc prolongation can be increased when Granisetron is combined with Arsenic trioxide.